Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early heart disease detection.
CDIO | US
Overview
Corporate Details
- ISIN(s):
- US56168P2039 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 311 W. SUPERIOR STREET, 60645 CHICAGO
Description
Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in the development and commercialization of clinical tests for cardiovascular disease. The company leverages a proprietary platform that integrates artificial intelligence with epigenetics and genetics to enable early detection and prevention of heart disease. Its primary products are blood-based tests, including Epi+Gen CHD and PrecisionCHD™, which assess a patient's risk for coronary heart disease. These diagnostic tools analyze an individual's unique genetic and epigenetic markers to provide personalized insights, aiming to make cardiovascular care more precise and accessible for clinicians and patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cardio Diagnostics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cardio Diagnostics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cardio Diagnostics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
